Published in J Cell Biochem on October 01, 2005
Regulation of hepatic paraoxonase-1 expression. J Lipids (2012) 0.85
Oxidative stress and mitochondrial functions in the intestinal Caco-2/15 cell line. PLoS One (2010) 0.82
Iron-ascorbate-mediated lipid peroxidation causes epigenetic changes in the antioxidant defense in intestinal epithelial cells: impact on inflammation. PLoS One (2013) 0.81
Extra Virgin Olive Oil Polyphenols Promote Cholesterol Efflux and Improve HDL Functionality. Evid Based Complement Alternat Med (2015) 0.78
Protective Role of Dietary Curcumin in the Prevention of the Oxidative Stress Induced by Chronic Alcohol with respect to Hepatic Injury and Antiatherogenic Markers. Oxid Med Cell Longev (2016) 0.77
Regulatory effects of dioxin-like and non-dioxin-like PCBs and other AhR ligands on the antioxidant enzymes paraoxonase 1/2/3. Environ Sci Pollut Res Int (2015) 0.75
Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure. Redox Biol (2013) 0.75
The Protective Effect of Naringenin-Oxime on Cisplatin-Induced Toxicity in Rats. Biochem Res Int (2017) 0.75
Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet (1995) 4.28
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol (1998) 3.79
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology (2000) 2.99
Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology (1999) 2.85
Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2. J Exp Med (1983) 2.61
The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol (1996) 2.57
Localization of the X inactivation centre on the human X chromosome in Xq13. Nature (1991) 2.48
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet (1995) 2.29
Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord (2004) 2.26
Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst (1996) 1.93
Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther (2007) 1.75
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest (1997) 1.71
Reverse transcriptase activity from human embryonal carcinoma cells NTera2D1. EMBO J (1990) 1.68
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64
Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem (1993) 1.57
Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol (2000) 1.53
The gene for incontinentia pigmenti is assigned to Xq28. Genomics (1989) 1.52
Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. Arch Dermatol (2001) 1.50
Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. N Engl J Med (1991) 1.48
Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology (2011) 1.48
A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology (2005) 1.45
The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res (2001) 1.45
Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood (1999) 1.45
Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocr Relat Cancer (2003) 1.44
Iatrogenic pneumocephalus secondary to intravenous catheterization. Case report. J Neurosurg (1999) 1.44
Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab (1999) 1.41
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy (2009) 1.41
Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology (1988) 1.41
Assessing the value of employee training. Health Care Manage Rev (1988) 1.39
Energy expenditure and substrates oxidative patterns, after glucose, fat or mixed load in normal weight subjects. Eur J Clin Nutr (1997) 1.39
Toxicologic evaluation of FK 506. Transplant Proc (1990) 1.36
Giving and receiving help: interpersonal transactions in mutual-help meetings and psychosocial adjustment of members. Am J Community Psychol (1999) 1.33
Cultural phenomena and the research enterprise: toward a culturally anchored methodology. Am J Community Psychol (1993) 1.33
Infant passenger safety education in perinatal services in California. West J Med (1982) 1.32
Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J (1995) 1.32
Genetic characterisation of Toxoplasma gondii in wildlife from North America revealed widespread and high prevalence of the fourth clonal type. Int J Parasitol (2011) 1.30
Thiamine-responsive maple-syrup-urine disease. Lancet (1971) 1.29
Hepatic changes produced by a single dose of endotoxin in the mouse. Electron microscopy. Am J Pathol (1968) 1.26
Functional complementation of a genetic deficiency with human artificial chromosomes. Am J Hum Genet (2001) 1.26
Structure and evolutionary origin of the gene encoding mouse NF-M, the middle-molecular-mass neurofilament protein. Eur J Biochem (1987) 1.24
Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut (2003) 1.23
FISH ordering of reference markers and of the gene for the alpha 5 subunit of the gamma-aminobutyric acid receptor (GABRA5) within the Angelman and Prader-Willi syndrome chromosomal regions. Hum Mol Genet (1993) 1.22
A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab (1997) 1.21
X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion. J Biol Chem (1998) 1.21
Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease. J Mol Med (Berl) (2001) 1.18
Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. J Pediatr (1992) 1.17
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta (1995) 1.16
Evolution of mouse B1 repeats: 7SL RNA folding pattern conserved. J Mol Evol (1991) 1.16
High intensity focused ultrasound--a surgical technique for the treatment of discrete liver tumours. Phys Med Biol (1989) 1.15
Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome. Pediatr Infect Dis J (1998) 1.15
The application of an automated hexosaminidase assay to genetic screening. Clin Chim Acta (1974) 1.15
Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J (1994) 1.15
Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem (1994) 1.15
Expression of a normal and variant Alzheimer's beta-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays. Biochem Biophys Res Commun (1990) 1.13
Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther (2009) 1.13
Hepatic changes produced by a single dose of endotoxin in the mouse. Light microscopy and histochemistry. Am J Pathol (1967) 1.13
Risk of childhood leukemia associated with diagnostic irradiation and polymorphisms in DNA repair genes. Environ Health Perspect (2000) 1.13
Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis (1999) 1.12
Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. Arterioscler Thromb Vasc Biol (1997) 1.12
Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations. J Lipid Res (2001) 1.12
Family size, day-care attendance, and breastfeeding in relation to the incidence of childhood asthma. Am J Epidemiol (2001) 1.12
The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13. Genomics (2001) 1.11
Expression of glypican 3 (GPC3) in embryonal tumors. Int J Cancer (2000) 1.10
Use of gamma irradiation to eliminate DNA contamination for PCR. Nucleic Acids Res (1990) 1.09
Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ (1999) 1.08
Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation. Atherosclerosis (2001) 1.08
Persistent pupillary membrane in basenji dogs. Vet Rec (1991) 1.08
Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochem Biophys Res Commun (1999) 1.08
Atypical MR appearance of Lhermitte-Duclos disease with contrast enhancement. AJNR Am J Neuroradiol (1995) 1.07
Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem (1994) 1.07
High incidence of upper gastrointestinal tract involvement in children with Crohn disease. Pediatrics (1989) 1.06
2-Amino-4-phosphonobutyric acid as a glutamate antagonist on locust muscle. Nature (1976) 1.06
Antibiotic prophylaxis for post-operative wound infection in clean elective breast surgery. Eur J Surg Oncol (2000) 1.05
Anorectal myomectomy in the treatment of short segment Hirschsprung's disease. Ann Surg (1969) 1.03
High resolution deletion mapping reveals frequent allelic losses at the DNA mismatch repair loci hMLH1 and hMSH3 in non-small cell lung cancer. Int J Cancer (1998) 1.03
Detection of virus-specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection by enzymeimmuno and radioimmunoassay techniques. Clin Exp Immunol (1982) 1.02
Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B. Chylomicron retention disease. Gastroenterology (1987) 1.02
A monoclonal anti-idiotypic antibody against anti-receptor antibodies from myasthenic sera. Eur J Immunol (1982) 1.02
Reduced brain choline in homocystinuria due to remethylation defects. Neurology (2008) 1.02
Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol (1993) 1.02
The human gamma-aminobutyric acid receptor subunit beta 3 and alpha 5 gene cluster in chromosome 15q11-q13 is rich in highly polymorphic (CA)n repeats. Genomics (1994) 1.01
DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine. Anticancer Drugs (1999) 1.01
Adolescent cystinosis: comparisons with infantile and adult forms. Pediatrics (1971) 1.01
Metabolic syndrome X: a review. Can J Cardiol (2000) 1.01
Allelic loss in childhood acute lymphoblastic leukemia. Leuk Res (1997) 1.01
Monophyletic origin of Alu elements in primates. J Mol Evol (1998) 1.00
Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia. Leukemia (2004) 1.00
Substrate-adhering lymphoid cells show impaired tumorigenicity and increased immunogenicity. Nature (1981) 1.00
Detection of specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection. Intervirology (1981) 1.00
Factors affecting the in-vitro development to blastocysts of bovine oocytes matured and fertilized in vitro. J Reprod Fertil (1991) 1.00
Dinucleotide repeat polymorphism at the GABAA receptor alpha 5 (GABRA5) locus at chromosome 15q11-q13. Hum Mol Genet (1992) 1.00
Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Anticancer Drugs (1998) 1.00
Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut (1996) 0.99
The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery. J Thromb Haemost (2003) 0.99
Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr (2000) 0.99
Linkage studies do not confirm the cytogenetic location of incontinentia pigmenti on Xp11. Hum Genet (1988) 0.99
Linkage mapping by simultaneous screening of multiple polymorphic loci using Alu oligonucleotide-directed PCR. Proc Natl Acad Sci U S A (1992) 0.99
Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer (2001) 0.99